Efficacy of Biologics in Terms of True Disease Modification
Dr. Gordon discusses how medication can be used to conceptualize and modify psoriasis.
Wednesday, January 25, 2023
Resource Tag: Biologics
Focus on Psoriasis: A Report from the 2022 IPC Think Tank – Miami
Under the title, What’s Next in Psoriasis? From Maintenance to Disease Modification, the 2022 IPC Think Tank scientific symposium was
Tuesday, January 24, 2023
Acceso a los Medicamentos Biológicos en Argentina: Repensando el Tiempo Hasta PASI 90
Los productos biológicos y biosimilares han creado muchas opciones nuevas en el tratamiento de la psoriasis para pacientes de todo
Wednesday, November 16, 2022
Access to Biologics in Argentina: Rethinking Time to PASI 90
Biologics and biosimilars have created many new options in psoriasis treatment for patients worldwide, but patients worldwide face barriers to
Wednesday, November 16, 2022
Acesso a Biológicos na Argentina: Repensando o Tempo para PASI 90
A psoríase e a tuberculose há muito andam de mãos dadas. Isto é especialmente verdade em certas partes do mundo,
Wednesday, November 16, 2022
Biologics: Modification Strategies
Biologics: Modification Strategies Marc Bourcier, MD, FRCPC, FAAD | Canada 2021https://www.youtube.com/watch?v=RQVf0PQP1c0
Friday, October 8, 2021
Biologics: Dose Optimization
Biologics: Dose Optimization Marc Bourcier, MD, FRCPC | Canada 2021
Friday, October 8, 2021
Network Meta-Analysis – What It Means for Us
Network Meta-Analysis – What It Means for Us Ronald Vender, MD, FRCPC | Canada2021https://www.youtube.com/watch?v=Cqk1pgZiZns
Tuesday, June 22, 2021
Challenging Case: Discusión Entre los Facultativos y La Audiencia
Challenging cases in psoriasis: A focus on COVID-19, biologics and adverse events faculty discussion.
Saturday, April 17, 2021
Caso Clínico 4: Eventos Adversos Cutáneos Durante la Terapia Biológica
Caso Clínico 4: Eventos Adversos Cutáneos Durante la Terapia Biológica André Carvalho | Brazil 2021
Saturday, April 17, 2021
